[1]张宇洋,孙雪静.骨髓穿刺涂片联合骨髓活检切片在骨髓增生异常综合征诊断中的应用[J].现代检验医学杂志,2016,31(02):139-140,143.[doi:10.3969/j.issn.1671-7414.2016.02.042]
 ZHANG Yu-yang,SUN Xue-jing.Value of Both Bone Marrow Biopsy and Smear in Diagnosis of Myelodysplastic Syndrome[J].Journal of Modern Laboratory Medicine,2016,31(02):139-140,143.[doi:10.3969/j.issn.1671-7414.2016.02.042]
点击复制

骨髓穿刺涂片联合骨髓活检切片在骨髓增生异常综合征诊断中的应用()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年02期
页码:
139-140,143
栏目:
检验与临床
出版日期:
2016-06-01

文章信息/Info

Title:
Value of Both Bone Marrow Biopsy and Smear in Diagnosis of Myelodysplastic Syndrome
作者:
张宇洋孙雪静
首都医科大学宣武医院,北京 100053
Author(s):
ZHANG Yu-yangSUN Xue-jing
Xuanwu Hospital of Capital Medical University,Beijing 100053,China
关键词:
骨髓增生异常综合征 骨髓涂片 骨髓活检
分类号:
R551.3; R446.8
DOI:
10.3969/j.issn.1671-7414.2016.02.042
文献标志码:
A
摘要:
目的 探讨骨髓穿刺涂片联合骨髓活检切片在骨髓增生异常综合征(myelodysplastic syndrome,MDS)诊断中的应用价值。方法 对59例血细胞减少患者采取骨髓穿刺和骨髓活检同步取材法,两种方法对其骨髓的增生程度,各系细胞的病态造血及网硬蛋白进行分析。结果 59例患者经骨髓活检切片观察其骨髓增生程度,其中增生活跃、明显活跃及极度活跃的患者共为53例,占89.8%; 骨髓穿刺涂片为40例,占67.8%,两者比较差异具有统计学意义(χ2=5.087,P=0.023)。26例MDS患者骨髓涂片发现粒系病态造血16例,占61.5%,骨髓切片为25例,占96.2%,两者比较差异具有统计学意义(χ2=5.092,P=0.021)。骨髓涂片发现红系病态造血24例,占92.3%,骨髓切片为7例,占26.9%,两者比较差异具有统计学意义,(χ2 =16.705,P=0.00)。骨髓涂片发现巨核系病态造血12例,占46.1%,骨髓切片为10例,占38.5%,两者比较差异无统计学意义(χ2=0.387,P=0.513)。26例MDS患者网硬蛋白纤维组织增生者16例,占61.5%; 33例非MDS患者为6例,占18.2%,MDS组患者显著高于非MDS组患者,两者比较差异具有统计学意义(χ2=10.086,P=0.001)。结论 骨髓穿刺涂片同时结合骨髓活检切片,可提高MDS诊断分型的准确性。
Abstract:
Objective To investigate the clinical significance of both marrow biopsy and smear methods for the diagnosis of myelodysplastic syndrome(MDS).Methods The bone marrow biopsy and aspiration were simultaneously conducted,and then histologic sections and cytologicsmears prepared and observed under microscope from 59 patients with pancytoniadysplastic.Results In 59 patients with pancytonia dysplastic diagnosed by both methods,the difference of bone marrow proliferative degree between histologic sections and cytologic smears was statistically significant(χ2=5.087,P=0.023).The detective rate of myeloid dysplasia in histologic sections was higher than that of cytologic smears(χ2=5.092,P=0.021).That of erythoid dysplasia in histologic sections was lower than that of cytologic smears(χ2=16.705,P=0.00),but that of megakaryoid dysplasiawas of no difference between these two methods(χ2=0.387,P=0.513)from26 patients with myelodysplastic syndromes.The results showed that of 26 MDS patients,16(61.5%)patients Gomori's stain showed positive.Of 33 Non-MDS patients,6(18.2%)patients Gomori's stain showed positive,and the difference was statistically significant significantly(χ2=10.086,P=0.001).Conclusion The histologic sections and cytologic smears have their advantages in the diagnosis of MDS,and the combination of these two methodswill achieve much better results.

参考文献/References:

[1] Garcia-Manero G. Myelodysplastic syndromes:2012 update on diagnosis,risk-stratification,and management[J].Am J Hematol,2012,87(7):692-701.
[2] Della Porta MG,Malcovati L,Strupp C,et al.Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome[J].Haematologica,2011,96(3):441-449.
[3] Jonas BA,Greenberg PL.MDS prognostic scoring systems-past,present,and future[J].Best Pract Res Clin Haematol,2015,28(1):3-13.
[4] Czader M,Orazi A.World Health Organization classification of myelodysplastic syndromes[J].Curr Pharm Des,2012,18(22):3149-3162.
[5] 张瑞妮,李 玲.骨髓增生异常综合征实验室检查及诊断技术的研究进展[J].白血病·淋巴瘤,2011,20(9):574-576. Zhang RN,Li L.Advances of study on laboratory examination and diagnosis technology of myelodysplastic syndromes[J].Journal of Leukemia & Lymphoma,2011,20(9):574-576.
[6] Garcia-Manero G.Myelodysplastic syndromes:2015 Update on diagnosis,risk-stratification and management[J].Am J Hematol,2015,90(9):831-841.
[7] 韦 巍,韦常丽.细胞浆内含有Auer样杆状小体的骨髓瘤1例[J].现代检验医学杂志,2014,29(6):51. Wei W,Wei CL.Auer rod like inclusions in multiple myeloma[J].JMod Lab Med,2014,29(6):51.
[8] 张延清,董家蔷,王京华,等.骨髓活检病理学检测在血液病诊断和鉴别诊断的价值[J].哈尔滨医科大学学报,2010,44(4):396-398. Zhang YQ,Dong JQ,Wang JH,et al.Clinic value of bone marrow histopathology in diagnosis and differential diagnosis of hematonosis[J].Journal of Harbin Medical University,2010,44(4):396-398.

相似文献/References:

[1]韩秀蕊,杨娣娣,李艳春,等.多发性骨髓瘤患者骨髓涂片与骨髓活检同步检查的比较分析[J].现代检验医学杂志,2015,30(03):129.[doi:10.3969/j.issn.1671-7414.2015.03.039]
 HAN Xiu-rui,YANG Di-di,LI Yan-chun,et al.Comparative Analysis of Bone Marrow Smears and Biopsies Synchronous Check for Myeloma Patients[J].Journal of Modern Laboratory Medicine,2015,30(02):129.[doi:10.3969/j.issn.1671-7414.2015.03.039]
[2]韩秀蕊,杨娣娣,赵 园,等.281例骨髓增生异常综合征患者染色体核型分析及临床意义的研究[J].现代检验医学杂志,2015,30(04):91.[doi:10.3969/j.issn.1671-7414.2015.04.025]
 HAN Xiu-rui,YANG Di-di,ZHAO Yuan,et al.Study on Chromosome Karyotype and Its Clinical Significance in 281 Cases of Myelodysplastic Syndromes[J].Journal of Modern Laboratory Medicine,2015,30(02):91.[doi:10.3969/j.issn.1671-7414.2015.04.025]
[3]聂 群,陈卓诚a,聂李平a,等.自动血细胞分析参数对骨髓增生异常综合征和再生障碍性贫血的鉴别诊断价值[J].现代检验医学杂志,2017,32(05):74.[doi:10.3969/j.issn.1671-7414.2017.05.017]
 NIE Qun,CHEN Zhuo-chenga,NIE Li-pinga,et al.Performance of Automatic Blood Cell Analysis Parameters for Differential Diagnosis of Myelodysplastic Syndromes and Aplastic Anemia[J].Journal of Modern Laboratory Medicine,2017,32(02):74.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[4]唐元艳,张利铭,张江召,等.骨髓增生异常综合征患者染色体异常与细胞形态学的相关性分析[J].现代检验医学杂志,2017,32(06):71.[doi:10.3969/j.issn.1671-7414.2017.06.001]
 TANG Yuan-yan,ZHANG Li-ming,ZHANG Jiang-zhao,et al.Correlation between Chromosomal Abnormality and Cell Morphology with Myelodysplastic Syndrome Patients[J].Journal of Modern Laboratory Medicine,2017,32(02):71.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[5]张冬梅,万顺伦,于丽华.骨髓增生异常综合征患者外周血单个核细胞中OTC4,Gli1 基因的表达及与预后的COX 回归分析[J].现代检验医学杂志,2022,37(06):58.[doi:10.3969/j.issn.1671-7414.2022.06.011]
 ZHANG Dong-mei,WANG Shun-lun,YU Li-hua.Expression of OTC4 and Gli1 Genes in Peripheral Blood Mononuclear Cells of Patients with Myelodysplastic Syndrome and Their Correlation with Prognosis by COX Regression Analysis[J].Journal of Modern Laboratory Medicine,2022,37(02):58.[doi:10.3969/j.issn.1671-7414.2022.06.011]
[6]张良子,左琴琴,吴大洲,等.1 例骨髓增生异常综合征多次受血患者血清存在抗-M,抗-cE 和抗-Jkb 抗体的鉴定及配血输血策略[J].现代检验医学杂志,2023,38(01):195.[doi:10.3969/j.issn.1671-7414.2023.01.037]
 ZHANG Liang-zi,ZUO Qin-qin,WU Da-zhou,et al.Identification and Transfusion Strategy of Anti-M,Anti-cE and Anti-Jkb Antibodies in the Serum of Patients with Myelodysplastic Syndromes Receiving Multiple Blood Transfusions[J].Journal of Modern Laboratory Medicine,2023,38(02):195.[doi:10.3969/j.issn.1671-7414.2023.01.037]
[7]曲志梅,董 伟,刘艳萍.维奈克拉增强MDS 细胞系对地西他滨化疗敏感性机制的实验研究[J].现代检验医学杂志,2023,38(03):53.[doi:10.3969/j.issn.1671-7414.2023.03.010]
 QU Zhi-mei,DONG Wei,LIU Yan-ping.Experimental Study on the Mechanism of Venetoclax Enhancing the Sensitivity of MDS Cell Lines to Decitabine Chemotherapy[J].Journal of Modern Laboratory Medicine,2023,38(02):53.[doi:10.3969/j.issn.1671-7414.2023.03.010]
[8]徐 娟a,贲海祥a,丁琳琳a,等.白细胞介素-1β 基因(rs16944)单核苷酸多态性与骨髓增生异常综合征易感性及临床特征的相关性研究[J].现代检验医学杂志,2023,38(04):51.[doi:10.3969/j.issn.1671-7414.2023.04.009]
 XU Juana,BEN Haixianga,DING Linlina,et al.Study on the Relationship between Single Nucleotide Polymorphism of Interleukin-1β (rs16944) Gene and Susceptibility and Clinical Characteristics of Myelodysplastic Syndromes[J].Journal of Modern Laboratory Medicine,2023,38(02):51.[doi:10.3969/j.issn.1671-7414.2023.04.009]
[9]杨艳敏,郝秀君,赵志芳,等.骨髓增生异常综合征患者骨髓中ABAT mRNA表达和ABAT甲基化水平对预后预测价值研究[J].现代检验医学杂志,2024,39(06):84.[doi:10.3969/j.issn.1671-7414.2024.06.014]
 YANG Yanmin,HAO Xiujun,ZHAO Zhifang,et al.Prognostic Value of ABAT mRNA Expression and ABAT Methylation Level in Bone Marrow of Patients with Myelodysplastic Syndrome[J].Journal of Modern Laboratory Medicine,2024,39(02):84.[doi:10.3969/j.issn.1671-7414.2024.06.014]

备注/Memo

备注/Memo:
作者简介:张宇洋(1975-),男,大专,技师,研究方向:病理学,Tel:010-83198810,E-mail:xuejing20100530@163.com。
更新日期/Last Update: 2016-02-20